Allison Mann

813 total citations
19 papers, 605 citations indexed

About

Allison Mann is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Safety Research. According to data from OpenAlex, Allison Mann has authored 19 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Safety Research. Recurrent topics in Allison Mann's work include Career Development and Diversity (4 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Allison Mann is often cited by papers focused on Career Development and Diversity (4 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Allison Mann collaborates with scholars based in United States, Japan and Switzerland. Allison Mann's co-authors include Thomas A. DiPrete, Carlos Perdomo, Milind M. Narurkar, William E. Rosenfeld, Rajesh Sachdeo, Blanca Vázquez, Martin J. Brodie, Santiago Arroyo, Gregory L. Krauss and Joscha Legewie and has published in prestigious journals such as Neurology, The Journal of the Acoustical Society of America and Epilepsia.

In The Last Decade

Allison Mann

18 papers receiving 578 citations

Peers

Allison Mann
George G. Thompson United Kingdom
Leonard Sax United States
Erin Dalton United States
Sarah O’Neill United States
Michelle B. Neiss United States
Karen Cai United States
Andrea Higgins United Kingdom
George G. Thompson United Kingdom
Allison Mann
Citations per year, relative to Allison Mann Allison Mann (= 1×) peers George G. Thompson

Countries citing papers authored by Allison Mann

Since Specialization
Citations

This map shows the geographic impact of Allison Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Mann more than expected).

Fields of papers citing papers by Allison Mann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Mann. The network helps show where Allison Mann may publish in the future.

Co-authorship network of co-authors of Allison Mann

This figure shows the co-authorship network connecting the top 25 collaborators of Allison Mann. A scholar is included among the top collaborators of Allison Mann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison Mann. Allison Mann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rattray, Nicholas A., et al.. (2024). Conceptualizing care partners' burden, stress, and support for reintegrating Veterans: a mixed methods study. Frontiers in Public Health. 11. 1295627–1295627. 2 indexed citations
2.
Wiendl, Heinz, Laura Airas, Tanuja Chitnis, et al.. (2022). Phase 3 REMODEL I/II Trials: Effectiveness, Safety, and Tolerability of Remibrutinib in Patients with Relapsing Multiple Sclerosis (P7-4.003). Neurology. 98(18_supplement). 1 indexed citations
3.
Jones, Graham B., et al.. (2022). Physician centricity in the deployment of digital solutions for neurological conditions. Digital Health. 8. 2282129920–2282129920.
4.
Dodick, David W., Stewart J. Tepper, Jessica Ailani, et al.. (2021). Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data. Headache The Journal of Head and Face Pain. 61(9). 1411–1420. 42 indexed citations
5.
Mann, Allison, et al.. (2019). Evaluation of pharmacy student perceptions and stereotypes of healthcare professionals before and after an internal medicine advanced pharmacy practice experience. Currents in Pharmacy Teaching and Learning. 11(4). 417–423. 3 indexed citations
6.
Mann, Allison. (2016). Beyond Medicalization: Explaining the Increased Prevalence of Attention Deficit-Hyperactivity Disorder. Columbia Academic Commons (Columbia University). 1 indexed citations
7.
Mann, Allison & Thomas A. DiPrete. (2016). The Consequences of the National Math and Science Performance Environment for Gender Differences in STEM Aspiration. Sociological Science. 3. 568–603. 33 indexed citations
8.
Mann, Allison, Joscha Legewie, & Thomas A. DiPrete. (2015). The role of school performance in narrowing gender gaps in the formation of STEM aspirations: a cross-national study. Frontiers in Psychology. 6. 171–171. 31 indexed citations
9.
Mann, Allison, et al.. (2014). Contextual landmark analysis of speech from typically and atypically developing children. The Journal of the Acoustical Society of America. 135(4_Supplement). 2293–2293. 1 indexed citations
10.
Mann, Allison & Thomas A. DiPrete. (2013). Trends in gender segregation in the choice of science and engineering majors. Social Science Research. 42(6). 1519–1541. 167 indexed citations
11.
Mann, Allison & Ronald J. Mann. (2011). Debt, Financial Distress, and Bankruptcy over the Life Course. 3 indexed citations
12.
Mann, Allison, et al.. (2011). Debt, Bankruptcy, and the Life Course. SSRN Electronic Journal. 3 indexed citations
13.
Mann, Allison & Thomas A. DiPrete. (2011). Trends in Gender Segregation in the Choice of Science and Engineering Majors. SSRN Electronic Journal. 2 indexed citations
14.
Elger, Christian E., H. Stefan, Allison Mann, et al.. (2010). A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures. Epilepsy Research. 88(2-3). 255–263. 50 indexed citations
15.
Biton, Victor, Gregory L. Krauss, Francesco Bibbiani, et al.. (2010). A randomized, double‐blind, placebo‐controlled, parallel‐group study of rufinamide as adjunctive therapy for refractory partial‐onset seizures. Epilepsia. 52(2). 234–242. 47 indexed citations
16.
Brodie, Martin J., William E. Rosenfeld, Blanca Vázquez, et al.. (2009). Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo‐controlled trial. Epilepsia. 50(8). 1899–1909. 111 indexed citations
17.
Wheless, James W., et al.. (2009). Safety and Tolerability of Rufinamide in Children With Epilepsy: A Pooled Analysis of 7 Clinical Studies. Journal of Child Neurology. 24(12). 1520–1525. 38 indexed citations
18.
Findling, Robert L., Nora McNamara, Robert J. Stansbrey, et al.. (2007). A Pilot Evaluation of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Memantine in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder Combined Type. Journal of Child and Adolescent Psychopharmacology. 17(1). 19–33. 57 indexed citations
19.
Bruce, Susan, et al.. (2007). Gestures Expressed by Children who are Congenitally Deaf-Blind: Topography, Rate, and Function. Journal of Visual Impairment & Blindness. 101(10). 637–652. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026